Topic

New York

A collection of 235 issues

How Long Does It Take to Get Prolastin-C Approved by UnitedHealthcare in New York? Complete Timeline & Appeals Guide

Answer Box: Getting Prolastin-C Approved by UnitedHealthcare in New York Timeline: Standard prior authorization decisions take 72 hours; expedited requests get 24-hour turnaround. Requirements: Pi*ZZ genotype confirmation, lung function tests showing impairment, and often trial/failure of preferred alternatives (Aralast NP, Glassia, Zemaira). First step: Gather complete documentation and
5 min read

Cigna's Coverage Criteria for Qinlock (Ripretinib) in New York: What Counts as "Medically Necessary"?

Quick Answer: Getting Qinlock (Ripretinib) Covered by Cigna in New York Cigna requires prior authorization for Qinlock (ripretinib) and enforces strict step therapy: you must have tried and failed imatinib, sunitinib, and regorafenib first. Medical necessity requires documented GIST diagnosis, progression after these three therapies, and oncologist prescription. First step
6 min read

Work With Your Doctor to Get Mycapssa (Octreotide, Oral) Approved by UnitedHealthcare in New York: Provider Partnership Guide

Quick Answer: Getting Mycapssa Covered in New York To get Mycapssa (octreotide, oral) approved by UnitedHealthcare in New York, you'll need to work closely with your endocrinologist to document prior response to injectable octreotide/lanreotide, submit comprehensive prior authorization with medical necessity justification, and be prepared for peer-to-peer
6 min read

How to Get Uptravi (Selexipag) Covered by UnitedHealthcare in New York: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Uptravi Covered by UnitedHealthcare in New York Uptravi (selexipag) requires prior authorization from UnitedHealthcare for pulmonary arterial hypertension (PAH) patients in New York. Your fastest path to approval: 1. Confirm WHO Group I PAH diagnosis with right heart catheterization results 2. Document step therapy (failed PDE5 inhibitors
7 min read

How to Get Rylaze (Asparaginase Erwinia Chrysanthemi) Covered by Cigna in New York: Complete Appeals Guide with State Protections

Answer Box: Getting Rylaze Covered by Cigna in New York Rylaze (asparaginase erwinia chrysanthemi) requires prior authorization from Cigna, with specific documentation of hypersensitivity to E. coli-derived asparaginase. Your fastest path to approval: (1) Gather proof of allergic reaction to Oncaspar/pegaspargase, (2) Have your oncologist complete Cigna's
6 min read